D.E. Shaw & Co’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,876
| Closed | -$505K | – | 3086 |
|
|
2024
Q4 | $505K | Sell |
9,876
-55,813
| -85% | -$2.85M | ﹤0.01% | 2396 |
|
|
2024
Q3 | $3.36M | Buy |
65,689
+26,123
| +66% | +$1.33M | ﹤0.01% | 1516 |
|
|
2024
Q2 | $1.77M | Buy |
39,566
+32,666
| +473% | +$1.46M | ﹤0.01% | 1877 |
|
|
2024
Q1 | $323K | Sell |
6,900
-10,105
| -59% | -$473K | ﹤0.01% | 2577 |
|
|
2023
Q4 | $605K | Sell |
17,005
-29,440
| -63% | -$1.05M | ﹤0.01% | 2294 |
|
|
2023
Q3 | $1.38M | Sell |
46,445
-24,145
| -34% | -$718K | ﹤0.01% | 1896 |
|
|
2023
Q2 | $1.27M | Buy |
+70,590
| New | +$1.27M | ﹤0.01% | 1974 |
|
|
2023
Q1 | – | Sell |
-31,417
| Closed | -$575K | – | 3363 |
|
|
2022
Q4 | $575K | Sell |
31,417
-5,738
| -15% | -$105K | ﹤0.01% | 2656 |
|
|
2022
Q3 | $730K | Buy |
37,155
+9,162
| +33% | +$180K | ﹤0.01% | 2700 |
|
|
2022
Q2 | $522K | Buy |
27,993
+12,972
| +86% | +$242K | ﹤0.01% | 3018 |
|
|
2022
Q1 | $330K | Sell |
15,021
-51,761
| -78% | -$1.14M | ﹤0.01% | 3404 |
|
|
2021
Q4 | $1.9M | Buy |
66,782
+24,687
| +59% | +$701K | ﹤0.01% | 2407 |
|
|
2021
Q3 | $886K | Buy |
42,095
+10,863
| +35% | +$229K | ﹤0.01% | 2553 |
|
|
2021
Q2 | $589K | Buy |
+31,232
| New | +$589K | ﹤0.01% | 2814 |
|
|
2020
Q3 | – | Sell |
-14,581
| Closed | -$255K | – | 2611 |
|
|
2020
Q2 | $255K | Buy |
+14,581
| New | +$255K | ﹤0.01% | 2381 |
|